Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MCRI | Options / Right to Buy | Sale | -$139K | -1.69K | -10.08% | $82.00 | 15.1K | Mar 3, 2022 | Common Stock | 1.69K | $45.74 | Direct | |
holding | MCRI | Options / Right to Buy | 15.1K | Mar 3, 2022 | Common Stock | 5K | $66.17 | Direct | F1 | |||||
holding | MCRI | Options / Right to Buy | 15.1K | Mar 3, 2022 | Common Stock | 3.33K | $66.17 | Direct | ||||||
holding | MCRI | Options / Right to Buy | 15.1K | Mar 3, 2022 | Common Stock | 3.33K | $44.60 | Direct | ||||||
holding | MCRI | Options / Right to Buy | 15.1K | Mar 3, 2022 | Common Stock | 3.33K | $43.03 | Direct | ||||||
holding | MCRI | Options / Right to Buy | 15.1K | Mar 3, 2022 | Common Stock | 104 | $45.74 | Direct |
Id | Content |
---|---|
F1 | On June 30, 2021, Mr. Koenig was granted 5,000 stock options, which vest as follow: (i) 1,666 stock options vest on June 30, 2024; (ii) 1,667 stock options vest on June 30, 2025; and (iii) 1,667 stock options vest on June 30, 2026. All stock options expire 10 years from the grant date, or approximately 7 years from the vesting date. |